Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Chronic pelvic pain biopsychosocial assessment
Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
A chronic label must not hide new danger
Collapse, pregnancy-related pain, acute peritonism, fever with systemic illness, heavy bleeding, urinary retention, bowel obstruction or a rapidly changing mass requires an acute pathway even when pelvic pain has existed for years.
Action: Reassess observations and the new symptom pattern, test for pregnancy when possible, investigate the urgent differential and escalate to the appropriate emergency service rather than attributing deterioration to a familiar chronic-pain diagnosis.
Overview
Assess persistent pelvic pain as a real multidimensional symptom, identify treatable and dangerous contributors, and build a shared plan that restores function without an endless diagnostic cycle.
Persistent pelvic pain often contains several overlapping components. Endometriosis, adenomyosis, previous pelvic infection, bladder pain syndrome, irritable bowel syndrome, constipation, inflammatory bowel disease, musculoskeletal dysfunction, nerve injury and adhesions may coexist with altered nociceptive processing. Sometimes a clear lesion accounts for much of the pain; sometimes no observable abnormality fully explains its intensity or impact. NICE distinguishes chronic secondary pain, attributed to an underlying condition, from chronic primary pain, where no condition adequately accounts for pain or its impact, and recognises that both can coexist.
Begin by hearing the person's account without prematurely sorting symptoms into physical or psychological boxes. Establish onset, location, radiation, quality, intensity, frequency, trajectory and flare pattern. A pain and symptom diary covering menstruation, bleeding, sex, bowel and bladder function, activity, sleep and medicines can expose patterns, but should not become burdensome surveillance. Ask about previous diagnoses, operations, pregnancy outcomes, pelvic infection, endometriosis treatment, imaging and what happened after each intervention.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA
Purpose of biopsychosocial assessment
A 34-year-old has pelvic pain for 2 years, a small treated endometrioma and substantial sleep, work and sexual disruption. Which statement best describes an appropriate biopsychosocial assessment?
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
The biopsychosocial history describes consequences as well as possible causes. Explore mobility, work or education, caring responsibilities, sleep, appetite, sexual wellbeing, fertility priorities, mood, anxiety, substance use, housing and financial pressures. Ask what sustains the person, what strategies already help and what a worthwhile improvement would look like. Enquire sensitively about trauma, abuse or coercion only in a private and safe setting, explaining relevance and allowing the person not to answer. Trauma is neither assumed nor presented as the explanation for pain.
Focused examination follows consent and a shared explanation of what each part may add. Observe movement and posture; assess abdomen, scars, hernia sites, back and hips. Carnett-type abdominal-wall findings or a discrete scar trigger point can shift attention away from visceral disease. Speculum and bimanual examination may identify discharge, bleeding, cervical lesions, uterine enlargement, masses, fixed retroversion, nodularity or tenderness. Pelvic-floor assessment can identify overactivity, impaired relaxation and trigger points, but an examination should be stopped when requested and deferred when distress outweighs immediate value.
Testing must be hypothesis-led. Offer pregnancy testing whenever relevant and STI testing when infection is plausible. Pelvic ultrasound is useful for masses, endometriomas, fibroids and adenomyosis but cannot exclude superficial endometriosis or every adhesion. NICE now advises transvaginal ultrasound for all suspected endometriosis even with a normal examination; a normal scan does not end that pathway. Urinalysis, culture, bowel tests, cancer referral or specialist imaging follow the symptom pattern. Repeating the same normal test without a changed question can reinforce uncertainty and delay rehabilitation.
Management is a coordinated portfolio rather than a sequence in which one failed test triggers another operation. Treat identified disease using its guideline while addressing sleep, activity, pelvic-floor dysfunction, constipation, sexual pain and medicine harms. For chronic primary pain, NICE supports a person-centred plan, supervised group exercise and consideration of acceptance and commitment therapy or cognitive behavioural therapy for pain. Those recommendations should not be misapplied to withhold disease-specific analgesia or hormonal treatment for chronic secondary pain.
Follow-up reviews function, adverse effects, diagnostic evolution and the person's priorities. A negative investigation should be communicated as useful information, not as proof that pain is unreal. Offer a clear route back for a changed phenotype and deliberately re-open the differential when new bleeding, systemic features, a mass, neurological change or loss of previous treatment response appears. Continuity and one coherent formulation reduce contradictory advice and repeated procedures.
Key points
Chronic pelvic pain is a symptom rather than one diagnosis; RCOG uses pain in the lower abdomen or pelvis lasting at least 6 months, while NICE defines chronic pain more generally as persisting or recurring for more than 3 months.
Biological, psychological and social assessment is additive: it validates pain, looks for disease and explains how sleep, stress, pelvic-floor guarding, work, relationships and prior experiences can amplify disability without implying that symptoms are imagined.
Map timing against menstruation, sex, bladder filling, urination, defecation, meals, posture and movement; strongly cyclical symptoms point toward hormonally driven disease but several mechanisms commonly coexist.
Ask what pain stops the person doing, including work, study, exercise, sleep, caring, intimacy and fertility plans; severity scores alone do not capture the treatment target.
Use focused, consented examination to test hypotheses, including abdominal wall, scars, back and hips as well as pelvic organs and pelvic-floor muscle tenderness when appropriate.
Choose investigations from the history: pregnancy and infection tests, ultrasound, endometriosis imaging, bowel or urinary assessment and cancer pathways each answer different questions; indiscriminate repeat testing can add harm without clarity.
Aetiology
01
Chronic secondary pain
Endometriosis, adenomyosis, previous infection, bladder or bowel disease, musculoskeletal dysfunction, nerve injury and selected adhesions can generate continuing nociceptive or neuropathic input.
02
Chronic primary pain
Pain may persist without a condition that adequately accounts for it or have an impact disproportionate to observable disease, reflecting altered pain processing and multiple contextual influences.
03
Overlapping contributors
A structural diagnosis, pelvic-floor guarding, sleep loss, fear, deconditioning and social stress commonly coexist, each modifying function and the salience of pain signals.
Pathophysiology
1
Peripheral sensitisation
Inflammation, tissue injury or nerve damage lowers local nociceptor thresholds, so ordinary movement, organ distension or touch can generate disproportionate afferent signalling.
2
Central amplification
Repeated nociceptive input can alter spinal and brain processing, widen receptive fields and reduce endogenous inhibition, allowing pain to persist after the initiating injury settles.
3
Viscero-visceral interaction
Converging pelvic organ pathways help explain why uterine, bowel and bladder symptoms overlap and why activity in one organ can increase sensitivity in another.
4
Protective muscle guarding
Anticipation of pain can produce sustained pelvic-floor and abdominal contraction, which creates fatigue, trigger points and further pain during sex, voiding or defecation.
Clinical features and red flags
Cyclical visceral phenotype
Pain linked strongly to periods, deep sex, defecation or urination suggests endometriosis or adenomyosis, although bowel and bladder symptoms may also vary through the cycle.
Pelvic-floor phenotype
Insertional pain, urinary or bowel emptying difficulty, muscle tenderness and inability to relax the pelvic floor support an overactivity component suitable for specialist physiotherapy.
Neuropathic phenotype
Burning, electric, shooting or dermatomal pain, allodynia and a scar-linked trigger suggest nerve injury or sensitisation and should shape examination and referral.
Chronic primary component
Widespread sensitivity, major functional impact and pain disproportionate to observable disease may indicate chronic primary pain alongside, rather than instead of, pelvic pathology.
Organ-specific phenotype
Pain with bladder filling relieved by voiding, altered bowel habit, rectal bleeding or focal musculoskeletal provocation should lead to the relevant specialty pathway.
Red flags requiring action
Unintentional weight loss, persistent abdominal distension, early satiety, a pelvic mass, postmenopausal bleeding or new pain after menopause requires timely malignancy assessment.
Rectal bleeding, nocturnal diarrhoea, iron-deficiency anaemia, persistent vomiting or a major change in bowel habit suggests gastrointestinal disease rather than uncomplicated chronic pelvic pain.
Investigations
01Pregnancy, infection and basic laboratory testsFirst step
Why
Exclude pregnancy-related disease, genital or urinary infection and measurable consequences such as anaemia when the history supports them.
Interpretation and limitations
Order selectively. Negative swabs do not exclude previous inflammatory damage, and normal inflammatory markers neither exclude endometriosis nor validate a chronic primary label.
02Transvaginal pelvic ultrasound
Why
Assess ovaries, endometriomas, uterus, adenomyosis features, fibroids and other structural pelvic disease when acceptable.
Interpretation and limitations
A normal scan is useful but does not exclude superficial endometriosis, pelvic-floor pain, neuropathic mechanisms or fine adhesions; do not describe it as a complete pelvic clearance.
03Specialist endometriosis ultrasound or pelvic MRI
Why
Map suspected deep endometriosis and involvement of bowel, bladder, ureter or other pelvic structures before specialist decisions.
Interpretation and limitations
Planning and interpretation need appropriate gynaecological imaging expertise. MRI is not a universal screening test for undifferentiated chronic pain.
04Symptom-directed bowel or urinary assessment
Why
Differential diagnosis
01
Endometriosis or adenomyosis
Marked cycle-related pain, dysmenorrhoea, deep dyspareunia and cyclical bowel or bladder symptoms support hormonally responsive pelvic disease despite normal routine imaging.
02
Bowel and bladder disorders
Irritable bowel syndrome, inflammatory bowel disease, constipation, bladder pain syndrome, infection and urinary tract obstruction can mimic or coexist with gynaecological pain.
03
Neuromusculoskeletal pain
Pelvic-floor overactivity, abdominal-wall trigger points, hip or sacroiliac pathology, hernia and postoperative nerve entrapment are revealed by movement and focused palpation.
04
Malignancy
Ovarian, endometrial, cervical, bowel or urinary cancer is less common but must be reconsidered with age, bleeding, mass, weight loss or altered organ function.
05
Chronic primary pain
When proportionate assessment finds no sufficient disease explanation, primary pain can be diagnosed positively while maintaining safety-netting for future diagnostic change.
Management
01First formulationMap pain, impact and danger togetherFirst stepPelvic pain has persisted or recurred and is impairing daily life.+
1Establish the temporal and organ pattern, prior interventions and red flags, then ask what matters most to the person and how pain affects function, sleep, relationships and wellbeing.
2Perform a consented, hypothesis-led examination and select pregnancy, infection, imaging or organ-specific tests only where results will alter the formulation or route.
3Share a written working formulation that names plausible contributors, acknowledges uncertainty and sets parallel diagnostic and treatment actions rather than promising a single hidden cause.
02Secondary-pain routeTreat identified mechanisms without tunnel visionHistory, examination or testing supports endometriosis, adenomyosis, infection sequelae, bladder, bowel, nerve or musculoskeletal disease.+
1
Complications
01
Functional restriction
Pain can progressively disrupt mobility, work, education, sleep, parenting, exercise and sexual activity, producing secondary deconditioning and loss of independence.
02
Procedure and medicine harm
Repeated operations can create adhesions and organ injury, while prolonged opioid or sedative use can cause tolerance, dependence, constipation, cognitive impairment and overdose risk.
03
Psychological and relational distress
Uncertainty, invalidation and persistent symptoms can contribute anxiety, low mood, isolation, fear of intimacy and relationship strain without making distress the original cause.
04
Delayed new diagnosis
Diagnostic closure around chronic pain can obscure later ectopic pregnancy, infection, bowel disease, urinary obstruction or malignancy when the clinical pattern changes.
Monitoring and follow-up
Track function chosen by the person, such as sleep, attendance, walking, bowel comfort or intimacy, alongside pain intensity and flare frequency.
Review adverse effects, sedation, constipation, tolerance and dependence for analgesic or psychotropic medicines and document the intended benefit and stop or taper plan.
Check completion and ownership of ultrasound, microbiology, histology and specialty referrals; fragmented results can perpetuate both risk and diagnostic uncertainty.
Repeat red-flag review whenever symptoms change, after menopause or when a previously effective treatment ceases to help.
Revisit fertility, contraception, sexual wellbeing, work and safeguarding priorities because these may change the acceptable balance between medical, rehabilitative and surgical options.
Special situations
Multiple mechanisms are expected
Identifying endometriosis does not make pelvic-floor tenderness or irritable bowel symptoms irrelevant; treating only the visible lesion may leave major pain drivers unchanged.
Normal results need careful language
Saying that imaging found no mass or endometrioma is accurate; saying that nothing is wrong invalidates pain and overstates what the test can detect.
Trauma enquiry needs permission
Previous or current trauma can affect health and examination tolerance, but disclosure must never be demanded or used as a convenient explanation for unexplained symptoms.
Chronic primary is not a default
It is a positive clinical formulation reached after proportionate assessment and may change over time; new signs still require investigation rather than diagnostic closure.
Goals can improve before pain disappears
Better sleep, confidence, mobility and participation are meaningful outcomes and can reduce disability even while a background pain signal remains.
Common pitfalls
01
Presenting a biopsychosocial assessment as evidence that pain is psychological or not real.
02
Repeating pelvic imaging or laparoscopy without stating the new question or how the result would change care.
03
Assuming a visible lesion explains every symptom and overlooking bowel, bladder, pelvic-floor, nerve or relationship effects.
04
Applying NICE chronic-primary-pain medicine restrictions indiscriminately to a person with a defined secondary condition requiring its own treatment.
05
Forcing an internal examination despite pain, trauma, lack of consent or little immediate diagnostic value.
06
Failing to investigate a new red flag because the record already carries a chronic pelvic pain diagnosis.
Agree parallel treatment for plausible secondary causes and pain mechanisms, with pelvic-health physiotherapy, condition-specific care and a multidisciplinary pain approach where appropriate.
Set functional and quality-of-life goals, a flare plan, review date and red flags; explain that improvement is possible even if no single lesion explains all pain.
Visible haematuria, recurrent culture-negative urinary symptoms with systemic features, hydronephrosis or impaired renal function requires urinary-tract evaluation and may indicate deep endometriosis or other pathology.
New focal neurological deficit, saddle sensory change, bladder or bowel retention, or severe back pain needs urgent neurological or spinal assessment.
Escalating distress, hopelessness, unsafe medicine use, self-harm thoughts, domestic abuse or sexual coercion requires compassionate direct enquiry and an immediate safety response.
Investigate haematuria, recurrent urinary symptoms, bladder-filling pain, altered bowel habit, inflammatory features or rectal bleeding.
Interpretation and limitations
Urinalysis, culture, renal imaging, faecal tests or endoscopy answer different questions; follow NICE cancer or specialty pathways when alarm features are present.
05Diagnostic laparoscopy
Why
Inspect for endometriosis and selected intraperitoneal pathology when suspicion persists and the result or planned treatment will change care.
Interpretation and limitations
It is an operation with possible injury and a meaningful chance of normal findings. It does not diagnose pelvic-floor, neuropathic, bladder or bowel pain and may create further adhesions.
Use the current condition-specific pathway and involve gynaecology, gastroenterology, urology or another specialty when its expertise will change treatment.
2Address accompanying pelvic-floor overactivity, sleep disruption, deconditioning, constipation, sexual pain and medicine burden because these can sustain symptoms after lesion treatment.
3EscalationReview whether response matches the proposed mechanism; non-response should trigger reformulation rather than automatic dose escalation or repeat surgery.
03Primary-pain routeBuild function while keeping review openNo condition adequately explains the pain or its impact, or a chronic primary component coexists with secondary pain.+
1Explain sensitisation in neutral language, validate that pain is real and agree goals such as sleep, attendance, mobility, intimacy or reduced flare disruption.
2Offer or refer for appropriate physical activity, pain-focused ACT or CBT and multidisciplinary pain input, with pelvic-health physiotherapy when examination supports muscle dysfunction.
3Review existing opioids, gabapentinoids or other dependence-forming medicines safely and collaboratively; do not stop abruptly, and apply NICE chronic-primary-pain prescribing recommendations only to the population they cover.
04Changed presentationRe-open the diagnostic framePain changes location, severity or associated symptoms, or a new red flag develops.+
1Repeat observations and focused history rather than assuming a routine flare, and use acute assessment for pregnancy, bleeding, infection, obstruction or neurological change.
2Reconsider age-related cancer risk and new bowel, urinary or gynaecological pathology with the relevant referral criteria.
3Update the shared formulation and flare plan after the episode so later clinicians can distinguish expected fluctuation from a new disease process.